Stock Research: Bausch Health Companies

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Bausch Health Companies

NYSE:BHC CA0717341071
25
  • Value
    48
  • Growth
    15
  • Safety
    Safety
    98
  • Combined
    49
  • Sentiment
    10
  • 360° View
    360° View
    25
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company. It operates in the pharmaceutical and medical device industries, with brands like Bausch + Lomb. It operates globally, including the U.S. and internationally. In the last fiscal year, the company had a market cap of $2378 million, profits of $6843 million, and revenue of $9625 million, with 20700 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 25 (better than 25% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bausch Health Companies are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Bausch Health Companies. Only the consolidated Value Rank has an attractive rank of 98, which means that the share price of Bausch Health Companies is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 98% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 15, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 48, meaning the company has a riskier financing structure than 52% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 90% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 10. ...read more

more
Index
TSX Composite
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 100 100 100
Growth
15 17 43 47
Safety
Safety
48 39 26 8
Sentiment
10 10 28 14
360° View
360° View
25 21 37 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
1 1 5 53
Opinions Change
50 28 75 35
Pro Holdings
n/a 76 91 74
Market Pulse
5 1 3 2
Sentiment
10 10 28 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 100 100 100
Growth
15 17 43 47
Safety Safety
48 39 26 8
Combined
49 55 62 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
100 96 100 100
Price vs. Earnings (P/E)
97 95 95 84
Price vs. Book (P/B)
96 96 95 98
Dividend Yield
1 1 1 1
Value
98 100 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
28 24 38 21
Profit Growth
34 50 49 34
Capital Growth
36 25 42 79
Stock Returns
31 39 65 73
Growth
15 17 43 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
5 7 5 9
Refinancing
87 65 69 5
Liquidity
54 53 49 61
Safety Safety
48 39 26 8

Similar Stocks

Discover high‑ranked alternatives to Bausch Health Companies and broaden your portfolio horizons.

Russel Metals

TSX:RUS
Country: Canada
Industry: Trading & Distribution
Size: Medium
Full Stock Analysis

Canadian Utilities

TSX:CU
Country: Canada
Industry: Multi-Utilities
Size: Medium
Full Stock Analysis

The North West

TSX:NWC
Country: Canada
Industry: Food Retail
Size: Medium
Full Stock Analysis

Bio-Techne

NasdaqGS:TECH
Country: USA
Industry: Life Sciences Tools & Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.